Immune/infectious disease

1.
Miriane de Oliveira, Maria T. De Sibio, Felipe A. S. Costa, Marna E. Sakalem. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19. ACS Biomaterials Science & Engineering. 2021;7(8):3487-3502. doi:10.1021/acsbiomaterials.1c00306
View Full Reference
1.
Bruna A. G. de Melo, Julia C. Benincasa, Elisa M. Cruz, Juliana Terzi Maricato, Marimelia A. Porcionatto. 3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting. Biomedical Journal. 2021;44(1):31-42. doi:10.1016/j.bj.2020.11.009
View Full Reference
1.
Vivek V. Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet-Dessimoz, John D. McKinney. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model. EMBO reports. 2021;22(6):e52744. doi:10.15252/embr.202152744
View Full Reference
1.
Yuling Han, Xiaohua Duan, Liuliu Yang, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270-275. doi:10.1038/s41586-020-2901-9
View Full Reference
1.
Lisa E. Wagar, Ameen Salahudeen, Christian M. Constantz, et al. Modeling human adaptive immune responses with tonsil organoids. Nature Medicine. 2021;27(1):125-135. doi:10.1038/s41591-020-01145-0
View Full Reference
1.
Joep Beumer, Maarten H. Geurts, Mart M. Lamers, et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nature Communications. 2021;12(1):5498. doi:10.1038/s41467-021-25729-7
View Full Reference
1.
Abbas Shafiee, Lida Moradi, Mayasari Lim, Jason Brown. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective. Stem Cells Translational Medicine. 2021;10(1):27-38. doi:10.1002/sctm.20-0197
View Full Reference
1.
Louisa Helms, Silvia Marchiano, Ian B. Stanaway, et al. Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations. JCI insight. 2021;6(24):e154882. doi:10.1172/jci.insight.154882
View Full Reference
1.
Bérénice Charrez, Verena Charwat, Brian A. Siemons, et al. Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics. Frontiers in Pharmacology. 2021;12:684252. doi:10.3389/fphar.2021.684252
View Full Reference
1.
Argus M. Sun, Tyler Hoffman, Bao Q. Luu, Nureddin Ashammakhi, Song Li. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review. Bio-Design and Manufacturing. 2021;4(4):757-775. doi:10.1007/s42242-021-00136-5
View Full Reference